Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$99.4B
| $349M | 0.06% |
1,991,800
+708,400
| +55% | +$128M |
|
227
Neurocrine Biosciences
NBIX
$16.5B
| $346M | 0.06% |
2,538,109
+773,519
| +44% | +$95.7M |
|
228
CALL
Apollo Global Management
APO
$82.8B
| $346M | 0.06% |
2,096,000
+659,200
| +46% | +$104M |
|
229
CALL
AbbVie
ABBV
$442B
| $345M | 0.06% |
1,942,300
-525,200
| -21% | -$96.6M |
|
230
CALL
Lam Research
LRCX
$390B
| $344M | 0.06% |
4,768,900
-593,100
| -11% | -$45M |
|
231
Cisco
CSCO
$475B
| $343M | 0.06% |
5,794,032
+652,812
| +13% | +$37.3M |
|
232
CALL
United Parcel Service
UPS
$88.8B
| $337M | 0.06% |
2,676,200
-765,000
| -22% | -$101M |
|
233
Dover
DOV
$28.1B
| $337M | 0.06% |
1,795,713
+581,715
| +48% | +$114M |
|
234
CALL
iShares MSCI EAFE ETF
EFA
$79.9B
| $336M | 0.06% |
4,447,000
-1,333,300
| -23% | -$106M |
|
235
DraftKings
DKNG
$12.6B
| $335M | 0.06% |
8,994,041
+2,198,447
| +32% | +$87.2M |
|
236
CALL
PepsiCo
PEP
$189B
| $333M | 0.06% |
2,193,000
-113,000
| -5% | -$18.5M |
|
237
PNC Financial Services
PNC
$101B
| $333M | 0.06% |
1,726,776
-1,715,769
| -50% | -$337M |
|
238
Humana
HUM
$44.8B
| $332M | 0.06% |
1,306,619
+789,227
| +153% | +$212M |
|
239
DexCom
DXCM
$33.8B
| $331M | 0.06% |
4,261,441
+3,027,597
| +245% | +$224M |
|
240
PUT
Vistra
VST
$48.6B
| $330M | 0.06% |
2,393,400
+82,900
| +4% | +$11.5M |
|
241
PUT
Marvell Technology
MRVL
$191B
| $329M | 0.06% |
2,983,100
+1,183,900
| +66% | +$110M |
|
242
Labcorp
LH
$26.1B
| $328M | 0.06% |
1,430,421
+1,296,573
| +969% | +$297M |
|
243
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
| $328M | 0.06% |
2,381,400
+1,490,900
| +167% | +$218M |
|
244
Wells Fargo
WFC
$264B
| $324M | 0.06% |
4,615,562
+2,510,148
| +119% | +$171M |
|
|
245
PUT
Spotify
SPOT
$103B
| $323M | 0.06% |
721,300
-486,800
| -40% | -$208M |
|
246
PUT
American Airlines Group
AAL
$10.1B
| $321M | 0.06% |
18,436,500
-6,059,000
| -25% | -$87.1M |
|
247
Mastercard
MA
$492B
| $319M | 0.06% |
606,468
-429,074
| -41% | -$222M |
|
248
CALL
GE Aerospace
GE
$382B
| $319M | 0.06% |
1,914,100
-1,795,600
| -48% | -$320M |
|
249
CALL
VanEck Gold Miners ETF
GDX
$27.5B
| $319M | 0.06% |
9,402,700
+1,244,400
| +15% | +$47.7M |
|
250
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.2B
| $318M | 0.06% |
746,500
-37,800
| -5% | -$16.4M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.